Merck & Co (NY: MRK )
106.39 +0.47 (+0.44%) Official Closing Price Updated: 7:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Headline News about Merck & Co
Merck & Co Earnings Preview
February 01, 2023
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
January 31, 2023
The year has started well for biopharma companies on the regulatory front, as most decisions handed out during January were positive. The Food and Drug Administration has already cleared four new...
Where Merck & Co Stands With Analysts
January 23, 2023
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed.
Can Cannabinoid CB2 Receptor Antagonist Combined With KEYTRUDA Be Effective In Patients With Advanced Solid Tumors? These Two Companies Aim To Find Out
January 18, 2023
Teon Therapeutics a clinical-stage biopharmaceutical company targeting metabolic signaling pathways and development of G-Protein Coupled Receptor immuno-oncology therapies in difficult-to-treat...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following